M4MM
Conservative Think Tank Advocates Federal Cannabis Labeling Standards to Address State Disparities
WASHINGTON – A prominent conservative policy group has called for federal guidance on Cannabis product warnings, pointing to stark differences in state regulations that leave consumers with inconsistent information on health risks. The American Enterprise ...
Psyence BioMed Ventures into Psilocybin’s Role in Aging Research
NEW YORK – Psyence BioMedical Ltd. disclosed its entry into longevity science with a new program probing psilocybin's influence on key aging indicators. The initiative, conducted alongside South African academics, marks the company's first foray ...
Kenyan MP Advocates for Regulated Cannabis Framework
NAIROBI – Peter Kalerwa Salasya, the outspoken member of Parliament for Kenya's Mumias East constituency, has ignited fresh debate on Сannabis policy by urging the government to pursue legalization under strict controls. Salasya highlighted the ...
Arkansas Medical Cannabis Sales Are Expected to Break Previous Record
LITTLE ROCK – Dispensaries in Arkansas have recorded $193.1 million in medical Cannabis sales from January through August, according to data from the state Department of Finance and Administration. This figure positions the market to ...
Rhode Island Launched Applications for Additional Cannabis Retail Licenses
PROVIDENCE – The Rhode Island Cannabis Control Commission has started taking applications for 24 additional adult-use Cannabis retail licenses, a step that expands the state's recreational market three years after legalization. The licenses are spread ...
Week In Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Wrapping up the first half of September 2025, it's worth noting that the Cannabis & Psychedelics industries continue proving their resilience amid political uncertainty and turbulent market dynamics. From stock rallies signaling ...
Former Arizona Senator Sinema Advocates Ibogaine Research Post-Treatment
LOS ANGELES – Former U.S. Senator Kyrsten Sinema of Arizona shared details of her personal encounter with ibogaine during a recent appearance on CNN. Speaking with Jake Tapper, Sinema highlighted her push for expanded research into ...
Conservative Think Tank Advocates Federal Cannabis Labeling Standards to Address State Disparities
WASHINGTON – A prominent conservative policy group has called for federal guidance on Cannabis product warnings, pointing to stark differences in state regulations that leave consumers with inconsistent information on health risks. The American Enterprise ...
Psyence BioMed Ventures into Psilocybin’s Role in Aging Research
NEW YORK – Psyence BioMedical Ltd. disclosed its entry into longevity science with a new program probing psilocybin's influence on key aging indicators. The initiative, conducted alongside South African academics, marks the company's first foray ...
Kenyan MP Advocates for Regulated Cannabis Framework
NAIROBI – Peter Kalerwa Salasya, the outspoken member of Parliament for Kenya's Mumias East constituency, has ignited fresh debate on Сannabis policy by urging the government to pursue legalization under strict controls. Salasya highlighted the ...
Minnesota Tests New Saliva-Based Roadside Cannabis Impairment Assessment
LOS ANGELES- In a groundbreaking move, Minnesota's Office of Traffic Safety (OTS) has initiated a pilot program to test a saliva-based roadside cannabis impairment test. This innovative approach is designed to enhance the state's capabilities ...
New York and Missouri’s Contrasting Cannabis Market Progress in 2023
NEW YORK- In a striking contrast of cannabis market development, New York and Missouri have reported significantly differing sales figures in 2023. New York's licensed cannabis dispensaries have achieved over $100 million in adult-use sales, ...
Cybin Inc. Secures $30 Million in Funding to Advance Psychedelic Treatment Research
NEW YORK- Toronto-based Cybin Inc., a clinical-stage biopharmaceutical company, has successfully completed a significant funding round, bolstering its commitment to revolutionize mental healthcare through the development of innovative psychedelic treatments. The company announced the closure ...
Clearmind Medicine Inc. Announces Reverse Share Split to Comply with Nasdaq Regulations
NEW YORK- Clearmind Medicine Inc., a biotech company renowned for its innovative work in developing psychedelic-derived therapeutics, has announced a strategic decision to conduct a reverse share split of its ordinary shares. This move is ...
Revive Therapeutics Advances Development of Innovative Bucillamine Formulation for Medical Emergencies
LOS ANGELES- Revive Therapeutics Ltd, a specialty life sciences company, has recently announced significant progress in the development of a new lyophilized formulation of Bucillamine, a drug initially designed for medical needs and rare disorders. ...
Oklahoma Prolongs Medical Cannabis License Moratorium to 2026 Amid Regulatory Review
LOS ANGELES- In a significant move for the state's cannabis industry, Oklahoma has decided to extend its moratorium on new medical cannabis licenses up to 2026, as reported by Tulsa World. This extension hinges on ...
New York Sets Stringent Regulations on Hemp Products, Banning Delta-8 and Other THC Variants
NEW YORK- New York's cannabis regulatory framework has reached a new milestone with the finalization of rules governing intoxicating hemp products. The state's regulators have imposed a ban on specific THC variants, including Delta-8 THC, ...
Pennsylvania Moves to Expand Medical Cannabis Retail Access, Breaking Up Potential Monopoly
NEW YORK- Pennsylvania is poised to significantly expand its medical cannabis industry, with new legislation on the horizon that could allow all of its 25 medical cannabis grower/processor licensees to also operate retail outlets. This ...
California Regulators Impose Embargo on Cannabis Products from Three Companies Over Safety Concerns
LOS ANGELES- California's Department of Cannabis Control (DCC) has taken decisive action by imposing an embargo on cannabis products from three companies, citing concerns that these products may have been "adulterated" and potentially harmful. This ...
South Dakota on the Cusp of Major Cannabis Reform with New Adult-Use Ballot Initiatives
LOS ANGELES- In a significant development for cannabis legislation, South Dakota has introduced two new adult-use cannabis legalization measures, aiming for inclusion in the 2024 general election. Both initiatives require 17,509 valid signatures from registered ...
Navigating the Green: Unraveling the Taxing Dilemma in the Cannabis Industry
LOS ANGELES- In the ever-expanding landscape of the cannabis industry, where green is not just a color but a thriving economic force, the question of taxation looms large. As states grapple with the complex task ...
Silo Pharma Secures Exclusive License for MedSpray’s Intranasal Technology for SPC-15 Drug Delivery
NERW YORK – Silo Pharma, Inc. a biopharmaceutical company at the forefront of merging traditional therapeutics with psychedelic research, announced today its new exclusive licensing agreement with Medspray Pharma BV. This agreement centers around Medspray's ...
New York Finalizes Regulations for Intoxicating Hemp Products, Banning Certain THC Variants
NEW YORK – New York's cannabis regulators have recently established definitive rules for intoxicating hemp products, introducing a series of restrictions and standards that are expected to reshape the hemp market in the state. As ...
Hawaii Attorney General Proposes Comprehensive Plan for Recreational Cannabis Legalization
LOS ANGELES– Hawaii Attorney General Anne Lopez recently unveiled a detailed proposal to legalize recreational cannabis, marking a significant step forward in the state's cannabis policy reform. This initiative comes eight months after a similar ...
Ohio Senate President Seeks Changes to Cannabis Legalization Law Amid Controversy
LOS ANGELES- In a move that is stirring debate, Ohio State Senate President Matt Huffman is spearheading a bipartisan effort to revise Ohio's recently approved cannabis legalization law, Issue 2, before its main provisions take ...
